Skip to content

Drug interactions

Atogepant + Griseofulvin

Severity: Moderate

Atogepant and Griseofulvin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Atogepant is a CYP3A4 substrate, and griseofulvin as a CYP3A4 inducer may reduce its concentrations. Lower exposure could decrease migraine prevention efficacy.

What this interaction means in plain words

Atogepant and Griseofulvin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Atogepant belongs to Central Nervous System; Griseofulvin belongs to Anti Fungals.

Evidence level: Low

Why it happens

CYP3A4 induction by griseofulvin increases atogepant metabolism.

What to do

Monitor migraine control; atogepant labeling advises dose adjustment with strong inducers, so consider an alternative to griseofulvin or review atogepant dosing if efficacy falls.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atogepant and Griseofulvin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Atogepant with Griseofulvin?

MediHelp rates the interaction as moderate. Atogepant and Griseofulvin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Atogepant is a CYP3A4 substrate, and griseofulvin as a CYP3A4 inducer may reduce its concentrations. Lower exposure could decrease migraine prevention efficacy.

How serious is the interaction between Atogepant and Griseofulvin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor migraine control; atogepant labeling advises dose adjustment with strong inducers, so consider an alternative to griseofulvin or review atogepant dosing if efficacy falls.

What other medicines interact with Griseofulvin?

MediHelp also lists interactions of Griseofulvin with, for example, Cyclosporin, Desogestrel-ethinyl estradiol, Dienogest / estradiol valerate. The full list is on the Griseofulvin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in